{"schema_version":"secwatch.filing_event.v1","accession":"0001097149-24-000007","form_type":"8-K","ticker":"ALGN","cik":"0001097149","company_name":"ALIGN TECHNOLOGY INC","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.355639+00:00","generated_at":"2026-06-06T12:50:21.524231+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Align Q4 rev $956.7M +6.1% YoY; EPS $1.64 ($2.42 non-GAAP); iTero Lumina launch; FY24 guide mid-single digit growth","bullets":["Q4 total revenue $956.7M (+6.1% YoY); GAAP diluted EPS $1.64; non-GAAP $2.42.","Clear Aligner revenue $781.9M (+6.9% YoY); volume 592,635 shipments (-0.6% YoY).","Full-year 2023 revenue $3.86B (+3.4%); GAAP diluted EPS $5.81; non-GAAP $8.61.","Unveiled iTero Lumina intraoral scanner with 3X wider field of capture and 50% smaller wand.","Q1 2024 revenue guidance $960M-$980M; FY2024 revenue expected up mid-single digits."],"urls":{"canonical":"https://secwatch.observer/filing/0001097149-24-000007","json":"https://secwatch.observer/filing/0001097149-24-000007.json","markdown":"https://secwatch.observer/filing/0001097149-24-000007.md","text":"https://secwatch.observer/filing/0001097149-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1097149/000109714924000007/0001097149-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1097149/000109714924000007/algn-20240131.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T12:50:21.524231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e5488f3faf473373c0ce560768d43204552294b","claim":"ALIGN TECHNOLOGY INC reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $956.7 million, net income $124.0 million, or $1.64 per diluted share, EPS $1.64 per diluted share.","evidence_excerpt":"margin was favorably impacted by foreign exchange of approximately 0.7 points compared to 2022 (5) • Repurchased $600 m illion of common stock in 2023 • Q4 total revenues of $956.7 million, and diluted net income per share of $1.64, non-GAAP diluted net income per share of $2.42 • Q4 revenues were unfavorably impacted by foreign exchange of approximately $12.8","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1097149/000109714924000007/0001097149-24-000007-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$956.7 million"},{"label":"Net income","value":"$124.0 million, or $1.64 per diluted share"},{"label":"EPS","value":"$1.64 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}